Core Biogenesis
PrivateLast Round
Series A
Jul 28, 2022
Total Funding Raised
$13.66M
Company Overview
Core Biogenesis is a biotechnology company that develops a plant-based bioproduction platform to manufacture recombinant proteins for the cell therapy, cellular agriculture, and skincare industries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Fashion & Beauty, Clean Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Core Biogenesis Comps
Public and private peers based on sector, stage, and business model.
Core Biogenesis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 28, 2022 | ||||
| Seed | Dec 14, 2020 |
Key People
Founding team and executive leadership
Core Biogenesis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Plug and Play Tech Center | Seed |
| Thia Ventures | Series A |
| XAnge | Seed, Series A |
| Entrepreneurs First | Seed, Series A |
| Blue Horizon Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2022
$11M round led by XAnge.
- Dec 14, 2020
$3.16M round led by XAnge.
Core Biogenesis Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Core Biogenesis's valuation, stock price, and market status.
